[go: up one dir, main page]

AU3170099A - Remedies for obesity - Google Patents

Remedies for obesity

Info

Publication number
AU3170099A
AU3170099A AU31700/99A AU3170099A AU3170099A AU 3170099 A AU3170099 A AU 3170099A AU 31700/99 A AU31700/99 A AU 31700/99A AU 3170099 A AU3170099 A AU 3170099A AU 3170099 A AU3170099 A AU 3170099A
Authority
AU
Australia
Prior art keywords
remedies
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31700/99A
Inventor
Hirotsune Itahana
Masamichi Okada
Hiromi Takeuchi
Fumikazu Wanibuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU3170099A publication Critical patent/AU3170099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31700/99A 1998-04-16 1999-04-14 Remedies for obesity Abandoned AU3170099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10641298 1998-04-16
JP10/106412 1998-04-16
PCT/JP1999/001992 WO1999053956A1 (en) 1998-04-16 1999-04-14 Remedies for obesity

Publications (1)

Publication Number Publication Date
AU3170099A true AU3170099A (en) 1999-11-08

Family

ID=14432966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31700/99A Abandoned AU3170099A (en) 1998-04-16 1999-04-14 Remedies for obesity

Country Status (2)

Country Link
AU (1) AU3170099A (en)
WO (1) WO1999053956A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
HRP20110278T1 (en) 2007-09-14 2011-05-31 Ortho-Mcneil-Janssen Pharmaceuticals 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4']bipyridinyl-2'-ones
JP5547194B2 (en) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 3-Azabicyclo [3.1.0] hexyl derivatives as modulators of metabotropic glutamate receptors
CN102232074B (en) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
CA2760259C (en) 2009-05-12 2018-05-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (en) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,4-Triazolo[4,3-A]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
WO2011067225A1 (en) * 2009-12-01 2011-06-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions targeting cb1 receptor for controlling food intake
CA2814996C (en) 2010-11-08 2019-10-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103261195B (en) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of the MGLUR2 receptor
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6, 7- dihydropyrazolu [5,1-a] pyrazine-4 (5 hands) -on compounds and their use as negative excretory regulators of Miglore 2 receptors.
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
KR20200036063A (en) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
EP3096790B1 (en) 2014-01-21 2019-07-10 Janssen Pharmaceutica, N.V. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0592438B1 (en) * 1990-10-15 1997-08-27 Pfizer Inc. Indole derivatives
RU2110516C1 (en) * 1992-04-10 1998-05-10 Пфайзер Инк. Derivatives of acylaminoindole and aminoindole
ATE170836T1 (en) * 1993-08-31 1998-09-15 Pfizer 5-ARYLINDOL DERIVATIVES
CA2213241C (en) * 1994-10-12 2001-07-10 Pfizer Research And Development Company, N.V./S.A. Indole derivative for the treatment of migraine

Also Published As

Publication number Publication date
WO1999053956A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AU6564598A (en) Snoring device
AU5497098A (en) Remedies for diabetes
AU2001246876A1 (en) Remedies
AU4191599A (en) Tele-diagnostic device
AU1810900A (en) Tele-diagnostic device
AU2001246877A1 (en) Remedies
AU3635499A (en) Z-peel sheets
AU3837300A (en) Remedies
AU3170099A (en) Remedies for obesity
AU3676100A (en) Remedies for neuropathic pain
AU3338899A (en) Micro-brewing device
AU5651799A (en) Remedies for photochemotherapy
AU1692699A (en) Pseudo-stereophony device
AU5544900A (en) Appliance for reducing snoring
AUPP593798A0 (en) Adjustable splint
AU3344399A (en) Remedies for primary biliary cirrhosis
AU6507599A (en) Anti-abduction device
AU2002224133A1 (en) Remedies for dermatophytosis
AU6114899A (en) Device
AU5688499A (en) Non-knotting line
AU5049499A (en) Orthopaedic device
AU2609599A (en) Sensor-coupling
AU3204999A (en) Futureball
AU2461200A (en) Remedies
AU5749698A (en) Ostomy device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase